Based on the information provided, it is important to know that the Omicron coronavirus subvariant JN.1 is now the leading cause of infections in the US, making up almost half of Covid-19 cases. Despite its rapid spread, there is no evidence that JN.1 presents an increased risk to public health in terms of causing more severe illness. The current vaccines, tests, and treatments are expected to be effective against JN.1. It is also important to note that overall Covid-19 hospitalizations have been trending down in recent weeks, while flu hospitalizations are rising but remain steady compared to recent weeks. It is crucial to stay informed about the latest updates and follow public health guidelines to stay safe.